ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,849.72
      -1.76%
      US Tech 100
      19,947.60
      0.33%
      Dow Jones
      43,191.24
      -1.48%
      Brent Oil
      70.62
      -1.09%
      Bitcoin
      83,963.57
      -2.47%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Keros Therapeutics Inc (KROS) Quote

      Keros Therapeutics Inc

      Keros Therapeutics Inc (KROS)

      NASDAQ
      11.10
      0.02
      (0.18%)
      Closed March 03 4:00PM
      Delayed by 15 minutes
      11.10
      0.00
      ( 0.00% )
      Pre Market: 4:00AM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      11.10
      Bid
      11.01
      Ask
      11.44
      Volume
      -
      0.00 Day's Range 0.00
      9.775 52 Week Range 72.37
      Market Cap
      450.239M
      Previous Close
      11.10
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,816,413
      Shares Outstanding
      40,562,047
      Dividend Yield
      -
      PE Ratio
      -2.94
      Earnings Per Share (EPS)
      -3.77
      Revenue
      151k
      Net Profit
      -152.99M

      About Keros Therapeutics Inc

      Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candida... Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.kerostx.com
      Headquarters
      Dover, Delaware, USA
      Founded
      -
      Keros Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker KROS. The last closing price for Keros Therapeutics was $11.10. Over the last year, Keros Therapeutics shares have traded in a share price range of $ 9.775 to $ 72.37.

      Keros Therapeutics currently has 40,562,047 shares outstanding. The market capitalization of Keros Therapeutics is $450.24 million. Keros Therapeutics has a price to earnings ratio (PE ratio) of -2.94.

      Ask ADVFN Intelligence (AI)

      KROS Latest News

      More News

      Form 8-K - Current report
      Edgar (US Regulatory)
      February 28 2025
      KROS (0.18%)

      Form S-8 - Securities to be offered to employees in employee benefit plans
      Edgar (US Regulatory)
      February 26 2025
      KROS (0.18%)

      Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
      Edgar (US Regulatory)
      February 26 2025
      KROS (0.18%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      February 26 2025
      KROS (0.18%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 19 2025
      KROS (0.18%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 19 2025
      KROS (0.18%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      February 19 2025
      KROS (0.18%)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.292.6827012025910.8111.4310.6301133774011.01376077CS
      4-0.01-0.090009000900111.1112.0510.09108827010.8503816CS
      12-56.18-83.50178359167.2869.2559.775181641314.17974736CS
      26-36.6-76.729559748447.772.379.775101859423.96069375CS
      52-58.9-84.14285714297072.379.77566968131.36155546CS
      156-38.29-77.525814942349.39739.77538444036.24221336CS
      260-9-44.77611940320.188.89.77528847139.06447102CS

      KROS - Frequently Asked Questions (FAQ)

      What is the current Keros Therapeutics share price?
      The current share price of Keros Therapeutics is $ 11.10
      How many Keros Therapeutics shares are in issue?
      Keros Therapeutics has 40,562,047 shares in issue
      What is the market cap of Keros Therapeutics?
      The market capitalisation of Keros Therapeutics is USD 450.24M
      What is the 1 year trading range for Keros Therapeutics share price?
      Keros Therapeutics has traded in the range of $ 9.775 to $ 72.37 during the past year
      What is the PE ratio of Keros Therapeutics?
      The price to earnings ratio of Keros Therapeutics is -2.94
      What is the cash to sales ratio of Keros Therapeutics?
      The cash to sales ratio of Keros Therapeutics is 3k
      What is the reporting currency for Keros Therapeutics?
      Keros Therapeutics reports financial results in USD
      What is the latest annual turnover for Keros Therapeutics?
      The latest annual turnover of Keros Therapeutics is USD 151k
      What is the latest annual profit for Keros Therapeutics?
      The latest annual profit of Keros Therapeutics is USD -152.99M
      What is the registered address of Keros Therapeutics?
      The registered address for Keros Therapeutics is 850 NEW BURTON ROAD, SUITE 201, DOVER, DELAWARE, 19904
      What is the Keros Therapeutics website address?
      The website address for Keros Therapeutics is www.kerostx.com
      Which industry sector does Keros Therapeutics operate in?
      Keros Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      PTIXProtagenic Therapeutics Inc
      $ 0.4812
      (74.16%)
      		9.34M
      BTOGBit Origin Ltd
      $ 0.4986
      (56.15%)
      		18.16M
      CDTConduit Pharmaceuticals Inc
      $ 1.60
      (37.93%)
      		1.93M
      SVRASavara Inc
      $ 3.00
      (29.31%)
      		67
      LGHLWLion Group Holding Ltd
      $ 0.0083
      (27.69%)
      		20
      SYRESpyre Therapeutics Inc
      $ 11.00
      (-38.68%)
      		3
      SPGCSacks Parente Golf Inc
      $ 0.1197
      (-37.00%)
      		4.16M
      OPCHOption Care Health Inc
      $ 22.01
      (-35.19%)
      		16
      EOLSEvolus Inc
      $ 9.32
      (-35.01%)
      		8
      MIRMMirum Pharmaceuticals Inc
      $ 32.01
      (-30.40%)
      		38
      BTOGBit Origin Ltd
      $ 0.4934
      (54.53%)
      		18.17M
      PTIXProtagenic Therapeutics Inc
      $ 0.4812
      (74.16%)
      		9.34M
      SPGCSacks Parente Golf Inc
      $ 0.1197
      (-37.00%)
      		4.16M
      SPPLSIMPPLE Ltd
      $ 0.482
      (16.00%)
      		2.12M
      CDTConduit Pharmaceuticals Inc
      $ 1.60
      (37.93%)
      		1.93M

      KROS Discussion

      View Posts
      TheFinalCD TheFinalCD 2 months ago
      $KROS halts all dosing in the TROPOS Phase 2 clinical trial of cibotercept (KER-012) based on the ongoing safety review due to new observations of pericardial effusion adverse events

      https://x.com/BioStocks/status/1879492237891080688

      $KROS the TROPOS trial is being terminated early. The Co continues to expect to present topline data from all treatment arms in this trial in Q2
      https://x.com/BioStocks/status/1879493199288586404
      👍️0
      retireat40 retireat40 2 months ago
      Wow. What a turd 
      👍️0
      retireat40 retireat40 3 months ago
      Shocked this is still sub 18
      👍️0
      Dennis14 Dennis14 3 months ago
      Bought in at 18.00
      👍️0
      Monksdream Monksdream 6 months ago
      KROS more upside possible

      👍️0
      Monksdream Monksdream 1 year ago
      KROS new 52=week high
      👍️0

      Your Recent History

      NASDAQ
      KROS
      Keros Therapeutics
      BIT
      UB593A
      Unicredit Bank
      BIT
      UC6GN1
      Unicredit Bank
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads